LENSAR, Inc. (LNSR) vs Pulmonx Corporation (LUNG)
LENSAR, Inc. and Pulmonx Corporation are both Medical Devices companies. LENSAR, Inc. and Pulmonx Corporation are of similar size ($86.9M and $81.6M). Pulmonx Corporation has negative trailing earnings, so its P/E is not meaningful; LENSAR, Inc. trades at 2.4×. LENSAR, Inc. grew revenue faster over the last twelve months: 3.26% against −3.43%. LENSAR, Inc. has the higher net margin (57.6% vs −55.0%) and the lower return on invested capital (−379.0% vs −141.0%). Across the 18 metrics below, Pulmonx Corporation leads on 10 and LENSAR, Inc. on 8.
Valuation
Profitability
| Metric | LNSR | LUNG | Medical Devices median |
|---|---|---|---|
| Gross margin | 48.34% | 77.06% | 56.01% |
| Operating margin | (13.48%) | (52.96%) | (15.03%) |
| Net margin | 57.57% | (55.03%) | (20.40%) |
| Free cash flow margin | (12.29%) | (35.07%) | (7.24%) |
| Return on equity | (851.75%) | (88.87%) | (15.32%) |
| Return on assets | 49.58% | (36.74%) | (19.72%) |
| Return on invested capital | (379.01%) | (141.03%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack